COVID-19 Asked & Answered: Differences in Vaccines

COVID-19 Asked & Answered: Differences in Vaccines

On Thursday, February 25th, the Food and Drug Administration is expected to vote on whether to issue an emergency use authorization to Johnson & Johnson’s (J&J) new single-dose COVID-19 vaccine candidate. If approved, it will join the Pfizer-BioNTech and Moderna vaccines in the ongoing rollout across the United States. Suresh Kuchipudi, clinical professor of veterinary and biomedical sciences, explains that, like the Pfizer and Moderna vaccines, the J&J vaccine is backed by years of research and has been shown through rigorous clinical trials to be safe and effective.